The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Open accessAbstract
All cancers develop as a result of mutations in certain genes, such as those involved in the regulation of cell growth and/or DNA repair, 1,2 but not all of these mutations are inherited from a parent.For example, sporadic mutations can occur in somatic/ tumor cells only, and de novo mutations can occur for the first time in a germ cell (i.e., egg or sperm) or in the fertilized egg itself during early embryogen-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–313 of 313
Lobular neoplasia: Long term risk of breast cancer and relation to other factors
Bodian, C. A., Perzin, K. H., & Lattes, R. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5<1024::aid-cncr12>3.0.co;2-4 · Cited by 170
Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers
Powell, C. B., Chen, L.-M., McLennan, J., Crawford, B., Zaloudek, C., Rabban, J. T., Moore, D. H., & Ziegler, J. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31821bc7e3 · Cited by 169
Self-citationFrequency of germline and somatic BRCA1 mutations in ovarian cancer.
Berchuck, A., Heron, K., Carney, M. E., Lancaster, J., Fraser, E. G., Vinson, V. L., Deffenbaugh, A. M., Miron, A., Marks, J. R., Futreal, P. A., et al. (1998) · PubMed · Cited by 169
The University of North Carolina at Chapel Hill University Libraries (2020) · PubMed · doi:10.17615/jkkh-v976 · Cited by 167
Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families
Tonin, P. N., Mes-Masson, A.-M., Futreal, P. A., Morgan, K., Mahon, M., Foulkes, W. D., Cole, D. E. C., Provencher, D., Ghadirian, P., & Narod, S. A. (1998) · The American Journal of Human Genetics · doi:10.1086/302099 · Cited by 165
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews
Kirchhoff, T., Kauff, N. D., Mitra, N., Nafa, K., Huang, H., Palmer, C., Gulati, T., Wadsworth, E., Donat, S., Robson, M. E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0604 · Cited by 165
Self-citationPilarski, R., Stephens, J. A., Noss, R., Fisher, J. L., & Prior, T. W. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2011.088807 · Cited by 165
Self-citationBreast Cancer Susceptibility Genes: BRCA1 and BRCA2
Brody, L. C., & Biesecker, B. B. (1998) · Medicine · doi:10.1097/00005792-199805000-00006 · Cited by 163
Mutations at BRCA1: the medullary breast carcinoma revisited.
Eisinger, F., Jacquemier, J. D., Charpin, C., Stoppa‐Lyonnet, D., Paillerets, B. B., Peyrat, J., Longy, M., Guinebretière, J., Sauvan, R., Noguchi, T., et al. (1998) · PubMed · Cited by 162
Rapid progression of prostate cancer in men with a BRCA2 mutation
the Hereditary Breast Cancer Study Group, Narod, S. A., Neuhausen, S., Vichodez, G., Armel, S., Lynch, H. T., Ghadirian, P., Cummings, S., Olopade, O., Stoppa-Lyonnet, D., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604453 · Cited by 162
Self-citationHerman, G. E., Butter, E., Enrile, B., Pastore, M., Prior, T. W., & Sommer, A. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31619 · Cited by 160
Oliveira, C., Bordin, M. C., Grehan, N., Huntsman, D., Suriano, G., Machado, J. C., Kiviluoto, T., Aaltonen, L., Jackson, C. E., Seruca, R., et al. (2002) · Human Mutation · doi:10.1002/humu.10068 · Cited by 159
Genetics of Cowden syndrome: through the looking glass of oncology.
Eng, C. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.701 · Cited by 157
Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome
Bennett, K. L. (2010) · JAMA · doi:10.1001/jama.2010.1877 · Cited by 155
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan, J. M., Boyd, J. A., Kauff, N. D., Robson, M. E., Scheuer, L., Narod, S. A., & Offit, K. (2002) · PubMed · Cited by 152
Self-citationBreast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
Neibergs, H. L. (2004) · The Women s Oncology Review · doi:10.1080/14733400410001682970 · Cited by 152
Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
Lustbader, E. D., Williams, W. R., Bondy, M. L., Strom, S. S., & Strong, L. C. (1992) · PubMed · Cited by 148
Gastric cancer in individuals with Li-Fraumeni syndrome
Masciari, S., Dewanwala, A., Stoffel, E. M., Lauwers, G. Y., Zheng, H. W., Achatz, M. I., Riegert‐Johnson, D. L., Foretová, L., da Silva, E. M., DiGianni, L. M., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31821628b6 · Cited by 148
Self-citationAssociations of High-Grade Prostate Cancer withBRCA1andBRCA2Founder Mutations
Agalliu, I., Gern, R. W., Leanza, S. M., & Burk, R. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1822 · Cited by 147
Murff, H. J., Byrne, D. W., & Syngal, S. (2004) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(04)00119-9 · Cited by 145
Dorval, M., Patenaude, A. F., Schneider, K. A., Kieffer, S. A., DiGianni, L. M., Kalkbrenner, K. J., Bromberg, J. I., Basili, L. A., Calzone, K., Stopfer, J. E., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2135 · Cited by 143
Self-citationEarly onset HER2‐positive breast cancer is associated with germline TP53 mutations
Melhem‐Bertrandt, A., Bojadzieva, J., Ready, K. J., Obeid, E. I., Liu, D. D., Gutierrez‐Barrera, A. M., Litton, J. K., Olopade, O. I., Hortobágyi, G. N., Strong, L. C., et al. (2011) · Cancer · doi:10.1002/cncr.26377 · Cited by 142
Self-citationGenetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome
Orloff, M. S., & Eng, C. (2008) · Oncogene · doi:10.1038/onc.2008.237 · Cited by 141
Thyroid pathologic findings in patients with Cowden disease
Harach, H. R., Soubeyran, I., Brown, A., Bonneau, D., & Longy, M. (1999) · Annals of Diagnostic Pathology · doi:10.1016/s1092-9134(99)80011-2 · Cited by 140
The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study
Beiner, M. E., Finch, A., Rosen, B. P., Lubiński, J., Møller, P., Ghadirian, P., Lynch, H. T., Friedman, E., Sun, P., & Narod, S. A. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.004 · Cited by 139
Woodward, E. R., Sleightholme, H., Considine, A., Williamson, S., McHugo, J. M., & Crüger, D. G. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01499.x · Cited by 137
Tsou, H. C., Teng, D. H. ‐., Ping, X. L., Brancolini, V., Davis, T., Hu, R., Xie, X. X., Gruener, A. C., Schrager, C. A., Christiano, A. M., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/301607 · Cited by 137
Menon, U., Harper, J. C., Sharma, A., Fraser, L. S. M., Burnell, M., Elmasry, K., Rodeck, C. H., & Jacobs, I. J. (2007) · Human Reproduction · doi:10.1093/humrep/dem055 · Cited by 137
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers
Evans, D. G., Gaarenstroom, K. N., Stirling, D., Shenton, A., Mæhle, L., Dørum, A., Steel, M., Lalloo, F. I., Apold, J., Porteous, M. E., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058248 · Cited by 137
Hereditary diffuse gastric cancer: association with lobular breast cancer
Schrader, K. A., Masciari, S., Boyd, N., Wiyrick, S. J., Kaurah, P., Senz, J., Burke, W., Lynch, H. T., Garber, J. E., & Huntsman, D. D. (2007) · Familial Cancer · doi:10.1007/s10689-007-9172-6 · Cited by 132
Self-citationKuusisto, K. M., Bebel, A., Vihinen, M., Schleutker, J., & Sallinen, S. (2011) · Breast Cancer Research · doi:10.1186/bcr2832 · Cited by 131
Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States
Ding, Y. C., Steele, L., Kuan, C.-J., Greilac, S., & Neuhausen, S. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1195-2 · Cited by 130
Lee, E., McKean‐Cowdin, R., Ma, H., SPICER, D. V., Berg, D. V. D., Bernstein, L., & Ursin, G. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.6446 · Cited by 130
Validity of Models for Predicting BRCA1 and BRCA2 Mutations
Parmigiani, G., Chen, S., Iversen, E. S., Friebel, T. M., Finkelstein, D. M., Anton-Culver, H., Ziogas, A., Weber, B. L., Eisen, A. F., Malone, K. E., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00002 · Cited by 126
Self-citationAnnual screening strategies in BRCA1 and BRCA2 gene mutation carriers
Lowry, K. P., Lee, J. M., Kong, C. Y., McMahon, P. M., Gilmore, M. E., Chubiz, J. E. C., Pisano, E. D., Gatsonis, C. A., Ryan, P. D., Ozanne, E. M., et al. (2011) · Cancer · doi:10.1002/cncr.26424 · Cited by 125
Gayther, S. A., Russell, P. A., Harrington, P. A., Antoniou, A. C., Easton, D. F., & Ponder, B. A. J. (1999) · The American Journal of Human Genetics · doi:10.1086/302583 · Cited by 124
Validating and Improving Models for Projecting the Absolute Risk of Breast Cancer
Gail, M. H., & Costantino, J. P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.334 · Cited by 124
BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
Haile, R. W., Thomas, D. C., McGuire, V. M., Felberg, A., John, E. M., Milne, R. L., Hopper, J. L., Jenkins, M. A., Levine, A. J., Daly, M. M., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0258 · Cited by 123
Self-citationGillanders, W. E., & Simon, P. O. (2005) · The Women s Oncology Review · doi:10.1080/14733400500235731 · Cited by 123
A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations: Table 1
Wilson, J. R. F., Bateman, A. C., Hanson, H., An, Q., Evans, G., Rahman, N., Jones, J. L., & Eccles, D. M. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.078113 · Cited by 122
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M. L. S., Lane, D. S., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000093674.44946.d6 · Cited by 119
Auranen, A., & Joutsiniemi, T. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01091.x · Cited by 118
Bardenstein, D. S., McLean, I. W., Nerney, J., & Boatwright, R. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33066-6 · Cited by 118
Epidemiology and risk assessment for ovarian cancer.
Daly, M. B., & Obrams, G. I. (1998) · PubMed · Cited by 115
Self-citationGenetic testing in autism: how much is enough?
Herman, G. E., Henninger, N., Ratliff-Schaub, K. L., Pastore, M., Fitzgerald‐Butt, S. M., & McBride, K. L. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31804d683b · Cited by 113
Available, N. A. N. (2004) · The Women s Oncology Review · doi:10.1080/14733400400013030 · Cited by 113
Narod, S. A., Lubiński, J., Ghadirian, P., Lynch, H. T., Møller, P., Foulkes, W. D., Rosen, B. P., Kim‐Sing, C., Isaacs, C. J., Domcheck, S., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70624-6 · Cited by 112
Thorne, H., Willems, A. J., Niedermayr, E., Hoh, I., Li, J., Clouston, D. R., Mitchell, G., Fox, S. B., Hopper, J. L., & Bolton, D. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0397 · Cited by 111
Novel PTEN mutations in neurodevelopmental disorders and macrocephaly
Orrico, A., Galli, L., Buoni, S., Orsi, A., Vonella, G., & Sorrentino, V. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01074.x · Cited by 105
Chompret, A. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01361-x · Cited by 104
Gynecologic Cancer Prevention in Lynch Syndrome/Hereditary Nonpolyposis Colorectal Cancer Families
Chen, L.-M., Yang, K. Y., Little, S. E., Cheung, M. K., & Caughey, A. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000267500.27329.85 · Cited by 104
Comen, E. A., Davids, M. S., Kirchhoff, T., Hudis, C. A., Offit, K., & Robson, M. E. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1433-2 · Cited by 103
Self-citationPalma, M. D., Domchek, S. M., Stopfer, J. E., Erlichman, J., Siegfried, J. D., Tigges-Cardwell, J., Mason, B. A., Rebbeck, T. R., & Nathanson, K. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0599 · Cited by 102
Weitzel, J. N., Lagos, V. I., Herzog, J., Judkins, T., Hendrickson, B. C., Ho, J. S., Ricker, C. N., Lowstuter, K. J., Blazer, K. R., Tomlinson, G. E., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0198 · Cited by 100
Self-citationClinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
Aida, H., Takakuwa, K., Nagata, H., et al. (1998) · PubMed · Cited by 99
Le‐Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., Litton, J. K., & Arun, B. (2011) · Cancer · doi:10.1002/cncr.25971 · Cited by 98
Self-citationKrutilkova, V., Trková, M., Fleitz, J. M., Gregor, V., Novotna, K., Křepelová, A., Sumerauer, D., Kodet, R., Širůčková, S., Plevová, P., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.026 · Cited by 97
Lee, E., Ma, H., McKean‐Cowdin, R., Berg, D. V. D., Bernstein, L., Henderson, B. E., & Ursin, G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0396 · Cited by 97
BRCA1 and pancreatic cancer: pedigree findings and their causal relationships
Lynch, H. T., Deters, C. A., Snyder, C., Lynch, J. F., Villeneuve, P. J. A., Silberstein, J., Martin, H., Narod, S. A., & Brand, R. E. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.01.032 · Cited by 95
Mouchawar, J., Korch, C. T., Byers, T., Pitts, T. M., Li, E., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Southey, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-0851 · Cited by 92
The effect of a single BRCA2 mutation on cancer in Iceland
Tulinius, H., Ólafsdóttir, G. H., Sigvaldason, H., Arason, A., Barkardottir, R. B., Egilsson, V., Ogmundsdottir, H. M., Tryggvadóttír, L., Gudlaugsdottir, S., & Eyfjord, J. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.7.457 · Cited by 89
Colonic Polyposis and Neoplasia in Cowden Syndrome
Stanich, P. P., Owens, V., Sweetser, S. R., Khambatta, S., Smyrk, T. C., Richardson, R. L., Goetz, M. P., & Patnaik, M. M. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0816 · Cited by 88
Risk-Reducing Salpingo-Oophorectomy in Women With a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., et al. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200209000-00016 · Cited by 86
Genetic Testing for Cancer Susceptibility
Calzone, K. A., & Soballe, P. W. (2008) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.05.003 · Cited by 85
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
Evans, D. G., Howell, A., Ward, D. G., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100006 · Cited by 83
Schaffer, J. V., Kamino, H., Witkiewicz, A. K., McNiff, J. M., & Orlow, S. J. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.5.625 · Cited by 81
Eerola, H., Heikkilä, P., Tamminen, A., Aittomäki, K., BLOMQVIST, C. P., & Nevanlinna, H. A. (2005) · Breast Cancer Research · doi:10.1186/bcr1025 · Cited by 80
Counseling for male BRCA mutation carriers – a review
Mohamad, H., & Apffelstaedt, J. (2008) · The Breast · doi:10.1016/j.breast.2008.05.001 · Cited by 80
Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers
Lee, L. J., Alexander, B. M., Schnitt, S. J., Comander, A. H., Gallagher, B. M., Garber, J. E., & Tung, N. (2011) · Cancer · doi:10.1002/cncr.25911 · Cited by 79
Self-citationCsókay, B., Udvarhelyi, N., Sulyok, Z., et al. (1999) · PubMed · Cited by 79
Bermejo, J. L., & Hemminki, K. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh474 · Cited by 77
Preimplantation Genetic Diagnosis for Cancer Syndromes
Offit, K., Sagi, M., & Hurley, K. E. (2006) · JAMA · doi:10.1001/jama.296.22.2727 · Cited by 76
Self-citationPreimplantation genetic diagnosis for BRCA1/2—a novel clinical experience
Sagi, M., Weinberg, N., Eilat, A., Aizenman, E., Werner, M., Girsh, E., Siminovsky, Y., Abeliovich, D., Peretz, T., Simon, A., et al. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2232 · Cited by 74
Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation-Negative Hereditary Breast Cancer Families
Kauff, N. D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D. J., Wadsworth, E., Lee, J., Cigler, T., Borgen, P. I., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji281 · Cited by 71
Self-citationLimitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic
Euhus, D., Leitch, A. M., Huth, J. F., & Peters, G. N. (2002) · The Breast Journal · doi:10.1046/j.1524-4741.2002.08005.x · Cited by 70
van Dijk, S., van Roosmalen, M. S., Otten, W., & Stalmeier, P. F. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5494 · Cited by 70
Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2
Goldfrank, D. J., Chuai, S., Bernstein, J. L., y Cajal, T. R., Lee, J. B., Alonso, M. C., Díez, O., Baiget, M., Kauff, N. D., Offit, K., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0176 · Cited by 67
Self-citationLippman, M. E., Cummings, S. R., Disch, D. P., Mershon, J. L., Dowsett, S. A., Cauley, J. A., & Martino, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0688 · Cited by 65
Clinical/genetic features in hereditary breast cancer
Lynch, H. T., Watson, P. A., Conway, T., & Lynch, J. F. (1990) · Breast Cancer Research and Treatment · doi:10.1007/bf01810778 · Cited by 61
Comen, E. A., & Robson, M. E. (2009) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(09)79253-7 · Cited by 61
Friedrichsen, D. M., Malone, K. E., Doody, D. R., Daling, J. R., & Ostrander, E. A. (2004) · Breast Cancer Research · doi:10.1186/bcr933 · Cited by 60
Autosomal Dominant Inheritance of Early-Onset Breast Cancer
Claus, E. B., RISCH, N. J., & Thompson, W. D. (1994) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199406000-00016 · Cited by 60
Kleihues, P., Ohgaki, H., & Hainaut, P. (2001) · Springer eBooks · doi:10.1007/978-3-642-56889-3_14 · Cited by 60
Bergman, A., Einbeigi, Z., Olofsson, U., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200704 · Cited by 58
Beyond Li-Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations
Gonzalez, K. D., Noltner, K., Buzin, C. H., Gu, D., Wen-Fong, C. Y., Ngyuen, V. Q., Han, J. H., Lowstuter, K., Longmate, J., Sommer, S. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.11031 · Cited by 58
Self-citationBRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
Bjørge, T., Lie, A. K., Hovig, E. J., Gislefoss, R. E., Hansen, S., Jellum, E., Langseth, H., Nustad, K., Tropé, C. G., & Dørum, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602199 · Cited by 57
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Mikaelsdottir, E., Valgeirsdóttir, S., Eyfjord, J. E., & Rafnar, Þ. (2004) · Breast Cancer Research · doi:10.1186/bcr785 · Cited by 53
The role of BRCA2 in replication-coupled DNA interstrand cross-link repair in vitro
Čipák, L., Watanabe, N., & Bessho, T. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1120 · Cited by 52
Association of common ATM polymorphism with bilateral breast cancer
Heikkinen, K., Rapakko, K., Karppinen, S., Erkko, H., Nieminen, P. A., & Winqvist, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20996 · Cited by 50
Understanding the functions of BRCA1 in the DNA-damage response
Yun, M. H., & Hiom, K. J. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370597 · Cited by 49
Hong, Y. C., Liu, H. M., Chen, P., Chen, Y. J., Lyou, J., Hu, H., Yi, M. F., Js, L., & Tzeng, C. H. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705823 · Cited by 43
Jasper, M. J., Liebelt, J. E., & Hussey, N. D. (2008) · Prenatal Diagnosis · doi:10.1002/pd.1925 · Cited by 43
Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations
Kim, D. H., Crawford, B., Ziegler, J. L., & Beattie, M. S. (2008) · Familial Cancer · doi:10.1007/s10689-008-9220-x · Cited by 43
Self-citationTwoATM variants and breast cancer risk
Thompson, D. J., Antoniou, A. C., Jenkins, M. A., Marsh, A. J., Chen, X., Wayne, T. L., Tesoriero, A. A., Milne, R. L., Spurdle, A. B., Thorstenson, Y. R., et al. (2005) · Human Mutation · doi:10.1002/humu.9344 · Cited by 42
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30
Ginsburg, O., Akbari, M. R., Aziz, Z., Young, R., Lynch, H. T., Ghadirian, P., Robidoux, A., Hernández, J. E. L., Vásquez, G., Gomes, M. C. B., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9287-z · Cited by 40
Self-citationFinch, A., Beiner, M. E., Lubiński, J., Lynch, H. T., Møller, P., Rosen, B. P., Murphy, J., Ghadirian, P., Friedman, E., Foulkes, W. D., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000251480.69322.50 · Cited by 38
Self-citationMiddleton, L. P. (2006) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(06)80427-3 · Cited by 37
Bonadona, V., Bonaïti, B., Olschwang, S., Grandjouan, S., Wang, Q., Bonaïti‐Pellié, C., & Lasset, C. (2011) · HAL · Cited by 36
Cowden's Disease: A Possible New Symptom Complex with Multiple System Involvement
(1963) · JAMA · doi:10.1001/jama.1963.03700080147102 · Cited by 36
The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds
Siddiqui, R., Onel, K., Facio, F. M., Nafa, K., Díaz, L. R., Kauff, N. D., Huang, H. J., Robson, M. E., Ellis, N. A., & Offit, K. (2005) · Familial Cancer · doi:10.1007/s10689-004-1946-5 · Cited by 33
Self-citationA case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis
Al‐Thihli, K., Palma, L., Marcus, V., Cesari, M., Kushner, Y. B., Barkun, A. N., & Foulkes, W. D. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1359 · Cited by 32
Familial risk for histology-specific bone cancers: An updated study in Sweden
Ji, J., & Hemminki, K. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.043 · Cited by 32
The American Cancer Society guidelines for breast screening with magnetic resonance imaging
Murphy, C., Lee, J. M., Drohan, B., et al. (2008) · Cancer · doi:10.1002/cncr.23913 · Cited by 28
ATM variants and cancer risk in breast cancer patients from Southern Finland
Tommiska, J., Jansen, L., Kilpivaara, O., Edvardsen, H., Kristensen, V. N., Tamminen, A., Aittomäki, K., BLOMQVIST, C. P., Børresen‐Dale, A., & Nevanlinna, H. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-209 · Cited by 27
Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America
Iniesta, M. D., Gorin, M. A., Chien, L.-C., Thomas, S. M., Milliron, K. J., Douglas, J. A., & Merajver, S. D. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.07.124 · Cited by 22
Brunet, J., Gutiérrez‐Enríquez, S., Torres, A., Bérez, V, Sanjosé, S., Galceran, J., Izquierdo, À., Menéndez, J., Gumà, J., & Borràs, J. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.00987.x · Cited by 21
Chibon, F., Primois, C., Bressieux, J. M., Lacombe, D., Lok, C., Mauriac, L., Taïeb, A., & Longy, M. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058131 · Cited by 20
Prophylactic Oophorectomy and Hormone Replacement Therapy: Protection at What Price?
Garber, J. E., & Hartman, A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.926 · Cited by 20
Self-citationClements, A., Robison, K. M., Granai, C. O., Steinhoff, M. M., Wilbur, J. S., & Moore, R. G. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181ae3f71 · Cited by 15
Thigpen, J. T. (2009) · Yearbook of Medicine · doi:10.1016/s0084-3873(09)79558-6 · Cited by 14
On the dynamics of breast tumor development in women carrying germline BRCA1 and BRCA2 mutations
Simon, R. M., & Zhang, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.23323 · Cited by 13
Tait, D. L. (2005) · The Women s Oncology Review · doi:10.1080/14733400500089708 · Cited by 13
Breast carcinoma genetics from a primary care perspective
Burke, W., Press, N. A., & Pinsky, L. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3+<543::aid-cncr4>3.0.co;2-a · Cited by 3
Cited by
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Self-citationRecent progress in the diagnosis and treatment of ovarian cancer
Jelovac, D., & Armstrong, D. K. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20113 · Cited by 765
Hennessy, B. T., Coleman, R. L., & Markman, M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61338-6 · Cited by 640
Metadata
- Authors
- Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., Kaklamani, V., Kohlmann, W., Kurian, A., Litton, J., Marcom, P. K., Nussbaum, R., Offit, K., Pal, T., Pasche, B., Pilarski, R., Reiser, G., Shannon, K. M., Smith, J. R., Swisher, E., & Weitzel, J. N.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2010-05
- Volume
- 8
- Issue
- 5
- Pages
- 562-594
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2112008163
- Cited by
- 646
- References
- 313
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.